Determining what represents value in the treatment of refractory or unexplained chronic cough from the perspective of key stakeholders in Spain using multi-criteria …
C Domingo, M Fernandez, N Garin, J Milara… - … Health Economics and …, 2023 - Springer
Abstract Background and Objective Chronic cough is defined as cough lasting for more than
8 weeks. It can be described as refractory when persisting despite thorough clinical …
8 weeks. It can be described as refractory when persisting despite thorough clinical …
[HTML][HTML] The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis
Abstract Introduction Dravet Syndrome (DS) is a severe, developmental epileptic
encephalopathy (DEE) that begins in infancy and is characterized by pharmaco-resistant …
encephalopathy (DEE) that begins in infancy and is characterized by pharmaco-resistant …
[HTML][HTML] Identifying key unmet needs and value drivers in the treatment of focal-onset seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through …
V Villanueva, M Carreño, A Gil-Nagel… - Epilepsy & Behavior, 2021 - Elsevier
Introduction Epilepsy is a serious neurological disease, ranking high in the top causes of
disability. Approximately 40% of patients with epilepsy are pharmacoresistant after their …
disability. Approximately 40% of patients with epilepsy are pharmacoresistant after their …
Value contribution of blood-based neurofilament light chain as a biomarker in multiple sclerosis using multi-criteria decision analysis
E Monreal, PD Ruiz, IL San Román… - Frontiers in Public …, 2024 - frontiersin.org
Introduction Multiple sclerosis (MS) is a chronic autoimmune demyelinating disease that
represents a leading cause of non-traumatic disability among young and middle-aged …
represents a leading cause of non-traumatic disability among young and middle-aged …
The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of …
X Badia, MÁ Calleja, V Escudero-Vilaplana… - Orphanet Journal of …, 2024 - Springer
Background The aim of this study was to assess the contribution of the reflective
multidisciplinary discussion in determining the value contribution of innovative drugs …
multidisciplinary discussion in determining the value contribution of innovative drugs …
[HTML][HTML] Contribution of cabotegravir+ rilpivirine long-acting for the treatment of HIV-1 infection
MÁ Calleja-Hernández, JM Martinez-Sesmero… - Farmacia …, 2022 - Elsevier
Objective To determine the value contribution of cabotegravir+ rilpivirine, the first injectable
every two months long-acting antiretroviral regimen, using multi-criteria decision analysis …
every two months long-acting antiretroviral regimen, using multi-criteria decision analysis …
Value contribution of etranacogene dezaparvovec gene therapy in moderately severe and severe haemophilia B through multi‐criteria decision analysis
DA García‐Diego, X Badia, O Benítez‐Hidalgo… - …, 2024 - Wiley Online Library
Introduction The value of gene therapies for haemophilia needs to be assessed holistically.
Aim To determine the value of etranacogene dezaparvovec (ED) compared to current …
Aim To determine the value of etranacogene dezaparvovec (ED) compared to current …
[HTML][HTML] 证据与价值对决策的影响
耿劲松, 鲍海妮, 余小兰 - 框架在知证决策中应用的方法学, 2020 - html.rhhz.net
探讨“证据与价值对决策的影响”(evidence and value: impact on decision-making, EVIDEM)
框架在知证决策中的应用. 经过文献检索和筛选, 共纳入22 篇文献进行分析. EVIDEM …
框架在知证决策中的应用. 经过文献检索和筛选, 共纳入22 篇文献进行分析. EVIDEM …
[HTML][HTML] Contribución de cabotegravir+ rilpivirina de acción prolongada al tratamiento de la infección por VIH-1
MÁ Calleja-Hernández, JM Martinez-Sesmero… - Farmacia …, 2022 - SciELO Espana
Objetivo: Determinar la contribución de valor de cabotegravir+ rilpivirina, el primer
tratamiento antirretroviral inyectable de acción prolongada, utilizando metodología de …
tratamiento antirretroviral inyectable de acción prolongada, utilizando metodología de …
Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi‐Criteria Decision Analysis
JF Silvestre, MJ Tribó, JC Armario‐Hita… - JEADV Clinical …, 2024 - Wiley Online Library
Background Prurigo nodularis (PN) is a chronic, debilitating dermatologic disease
characterised by the presence of highly pruritic nodular lesions. PN highly impacts on …
characterised by the presence of highly pruritic nodular lesions. PN highly impacts on …